Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2000
09/27/2000CN1267670A Two aporphine-benzyl isoquinoline compounds with antineoplastic activity
09/27/2000CN1267532A Biaining as one medicine for nasopharyngeal cancer
09/27/2000CN1267519A Immune regulator, immune regulator food and immune regulator fodder
09/27/2000CN1056851C Cyclic adhesion inhibitors
09/27/2000CN1056844C Dioxide pyrrolo-pyrrolo derivatives
09/27/2000CN1056835C Novel selective aromatase inhibiting compounds
09/27/2000CN1056773C Medical liquid for recovering cancer and tumour
09/27/2000CN1056752C Traditional Chinese medicine oral liquid for anti-cancer
09/27/2000CN1056748C Application of rhizoma bolbostemmae glucoside for preparing medicine to treat leukaemia
09/26/2000US6124455 Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity
09/26/2000US6124450 Processes and intermediates for phosphorous-containing covalent linkages
09/26/2000US6124342 Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds
09/26/2000US6124332 Metalloproteinase inhibitors
09/26/2000US6124330 N-[4-(Heteroarylmethyl)phenyl]-heteroarylamines
09/26/2000US6124329 Metalloproteinase inhibitors
09/26/2000US6124311 Administering oncolytic agent with enhanced multidrug resistance reversing amount of specified compound
09/26/2000US6124310 Enediyne compounds
09/26/2000US6124296 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
09/26/2000US6124293 Semi-synthetic ecteinascidins
09/26/2000US6124292 Antitumor agents
09/26/2000US6124288 Phosphodiesterase iv inhibitors
09/26/2000US6124263 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists
09/26/2000US6124261 Non-aqueous polar aprotic peptide formulations
09/26/2000US6124095 Human nucleotide pyrophosphohydrolase-2
09/26/2000US6123938 Human urinary hyaluronidase
09/26/2000US6123916 For treating disorders with an aetiology comprising or associated with excess of gh-secretion
09/26/2000CA1341102C Tetra-aza macrocycles and metal complexes thereof
09/21/2000WO2000055633A2 Methods of screening for colorectal cancer modulators
09/21/2000WO2000055371A1 27 human secreted proteins
09/21/2000WO2000055352A2 50 human secreted proteins
09/21/2000WO2000055351A1 Human colon cancer associated gene sequences and polypeptides
09/21/2000WO2000055350A1 Human cancer associated gene sequences and polypeptides
09/21/2000WO2000055345A2 Therapy of cancer by insect cells containing recombinant baculovirus encoding genes
09/21/2000WO2000055344A1 Adenoviral vector expressing a sv40 t antigen antisense rna
09/21/2000WO2000055332A2 Human regulators of intracellular phosphorylation
09/21/2000WO2000055321A2 Vertebrate protein slit, dna sequence encoding it and uses thereof
09/21/2000WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
09/21/2000WO2000055318A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels
09/21/2000WO2000055201A1 49 human secreted proteins
09/21/2000WO2000055200A1 50 human secreted proteins
09/21/2000WO2000055199A1 47 human secreted proteins
09/21/2000WO2000055190A1 Novel lhrh antagonists with improved solubility characteristics
09/21/2000WO2000055183A1 Method for refolding molecules of polypeptides containing ig domains
09/21/2000WO2000055180A2 Human lung cancer associated gene sequences and polypeptides
09/21/2000WO2000055177A2 49 human secreted proteins
09/21/2000WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides
09/21/2000WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides
09/21/2000WO2000055171A1 50 human secreted proteins
09/21/2000WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS
09/21/2000WO2000055162A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
09/21/2000WO2000055161A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
09/21/2000WO2000055160A1 Pharmaceutical composition based on polyaromatic compounds
09/21/2000WO2000055159A2 Substituted aza-oxindole derivatives
09/21/2000WO2000055155A2 Heterocyclic compounds as adenosine deaminase inhibitors
09/21/2000WO2000055141A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/21/2000WO2000055137A1 Compounds and methods for modulation of estrogen receptors
09/21/2000WO2000055134A1 Substituted 1-oxo- and 1,3-dioxoisoindolines and their use in pharmaceutical compositions for reducing inflammatory cytokine levels
09/21/2000WO2000055128A1 Methods and compositions for treating leukemia
09/21/2000WO2000055126A2 N-cyanomethylamides as protease inhibitors
09/21/2000WO2000055125A2 N-cyanomethyl amides as protease inhibitors
09/21/2000WO2000054815A2 Expression of dna or proteins in c. elegans
09/21/2000WO2000054807A1 Ligand-bonded complex
09/21/2000WO2000054806A1 Insulin-like growth factor binding protein-4 protease
09/21/2000WO2000054805A1 SURFACE LOCALIZED COLLIGIN/HsP47 IN CARCINOMA CELLS
09/21/2000WO2000054802A2 Method of expressing antigens on the surface of antigen presenting cells by photochemical internalization
09/21/2000WO2000054801A1 Compositions and methods of use of ldl-like receptor ligands for the treatment of cancer and angiogenic-based disease
09/21/2000WO2000054797A2 Pharmaceutical compositions comprising tgf-beta
09/21/2000WO2000054796A1 Novel antiangiogenic peptides
09/21/2000WO2000054790A1 Immunostimulant bacterial membrane fractions in cancer treatment
09/21/2000WO2000054789A1 Bacterial membrane fractions with adjuvant effect
09/21/2000WO2000054782A1 Treatment of accidental extravasation of anthracyclines
09/21/2000WO2000054770A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000WO2000054762A2 Use of cross linked polysaccharides for the inhibition of angiogenesis
09/21/2000WO2000043043B1 Ligand-peg post-coating stabilized lipoplex and polyplex for targeted gene delivery
09/21/2000WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy
09/21/2000WO2000039292A3 Antisense oligonucleotide for inhibiting the expression of the adhesion molecule very late antigen 4 (vla-4) in human cells
09/21/2000WO2000039077A3 Thyroid receptor ligands
09/21/2000WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors
09/21/2000WO2000027207A8 Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
09/21/2000WO2000025819A9 Enhanced radiation therapy
09/21/2000WO2000021560A9 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
09/21/2000WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization
09/21/2000WO2000012508A3 Pyrrolbenzodiazepines
09/21/2000WO2000010602A9 Lats knock-out animal models and their uses
09/21/2000WO2000004865A3 Synthetic techniques and intermediates for polyhydroxy, dienyl lactone derivatives
09/21/2000WO2000001668A3 Naaladase inhibitors useful as pharmaceutical compounds and compositions
09/21/2000DE19911510A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19911509A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation
09/21/2000DE19911329A1 Humantherapeutisch anwendbares Radioimmunkonjugat und Verfahren zu seiner Herstellung Human Therapeutic applicable radioimmunoconjugate and process for its preparation
09/21/2000DE19910697A1 Natural medicament useful for treating inflammation, rheumatism or skin disease, obtained from Aloe genus plants, honey and ethanol
09/21/2000CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators
09/21/2000CA2368148A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368122A1 Novel compounds and compositions as protease inhibitors
09/21/2000CA2368068A1 27 human secreted proteins
09/21/2000CA2367917A1 Bacterial membrane fractions with adjuvant effect
09/21/2000CA2367906A1 Tcl-1b gene and protein and related methods and compositions
09/21/2000CA2367895A1 Compounds and methods for modulation of estrogen receptors
09/21/2000CA2367611A1 Pharmaceutical compositions comprising troponin subunits, fragments and homologs thereof and methods of their use to inhibit angiogenesis
09/21/2000CA2367357A1 Method
09/21/2000CA2367354A1 6-substituted biaryl purine derivatives as potent cyclin/cdk inhibitors and antiproliferative agents
1 ... 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 ... 2211